Associations between serum leptin level and bone turnover in kidney transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 12, 2010, Pages 2297-2304

  Kovesdy, Csaba P ^a,b   Molnar, Miklos Z ^c,d   Czira, Maria E ^c   Rudas, Anna ^c   Ujszaszi, Akos ^c   Rosivall, Laszlo ^c   Szathmari, Miklos ^c   Covic, Adrian ^e   Keszei, Andras ^f   Beko, Gabriella ^c   Lakatos, Peter ^c   Kosa, Janos ^c   Mucsi, Istvan ^c,g  

^a Division of Nephrology   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CROSSLAP; BIOLOGICAL MARKER; LEPTIN; OSTEOCALCIN; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ARTICLE; BONE METABOLISM; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; VITAMIN D DEFICIENCY;

ADULT; AGED; BONE REMODELING; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LEPTIN; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDES; VITAMIN D;

EID: 78650371013     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03520410     Document Type: Article

References (48)

1. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007
2. De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM: The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13: 2762-2769, 2002
3. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of timevarying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
4. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73: 1296-1302, 2008
5. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS: Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57: 329-335, 1995
6. Martinez I, Saracho R, Montenegro J, Llach F: The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29: 496-502, 1997
7. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB: Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67: 876-881, 1988
8. St John A, Thomas MB, Davies CP, Mullan B, Dick I, Hutchison B, van der SA, Prince RL: Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron 61: 422-427, 1992
9. Fuleihan GE, Gundberg CM, Gleason R, Brown EM, Stromski ME, Grant FD, Conlin PR: Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab 79: 1642-1647, 1994
10. Gupta A, Kallenbach LR, Zasuwa G, Divine GW: Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 11: 330-334, 2000
11. Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ Jr., Feduska NJ, Salvatierra O Jr: Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 25: 677-682, 1984
12. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S: Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76: 370-373, 1985 (Pubitemid 15243466)
13. Kamycheva E, Sundsfjord J, Jorde R: Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 151: 167-172, 2004
14. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA: The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89: 1196-1199, 2004
15. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690-693, 2000
16. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC, Lips P: Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women. J Clin Endocrinol Metab 90: 4119-4123, 2005
17. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease. Clin J Am Soc Nephrol 2: 1024-1029, 2007
18. Saab G, Whaley-Connell A, McFarlane SI, Li S, Chen SC, Sowers JR, McCullough PA, Bakris GL: Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. Metabolism 59: 385-389, 2010
19. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH: Low circulating vitamin D in obesity. Calcif Tissue Int 43: 199-201, 1988
20. Kawai M, Devlin MJ, Rosen CJ: Fat targets for skeletal health. Nat Rev Rheumatol 5: 365-372, 2009
21. Coen G, Ballanti P, Fischer MS, Balducci A, Calabria S, Colamarco L, Di ZG, Lifrieri F, Manni M, Sardella D, Nofroni I, Bonucci E: Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 42: 1036-1042, 2003
22. Zoccali C, Panuccio V, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F: Leptin and biochemical markers of bone turnover in dialysis patients. J Nephrol 17: 253-260, 2004
23. Karthikeyan V, Karpinski J, Nair RC, Knoll G: The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 4: 262-269, 2004
24. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH: High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11: 1093-1099, 2000
25. Torres A, Rodriguez AP, Concepcion MT, Garcia S, Rufino M, Martin B, Perez L, Machado M, de BE, Losada M, Hernandez D, Lorenzo V: Parathyroid function in longterm renal transplant patients: Importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 13[Suppl 3]: 94-97, 1998
26. Velasquez-Forero F, Mondragon A, Herrero B, Pena JC: Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 11[Suppl 3]: 58-64, 1996
27. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C: Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 80: 864-868, 1995
28. Power MJ, Fottrell PF: Osteocalcin: Diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 28: 287-335, 1991
29. Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC: Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7: 506-512, 1996 (Pubitemid 26128321)
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999 (Pubitemid 29135798)
31. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
32. Bablok W, Passing H, Bender R, Schneider B: A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem 26: 783-790, 1988
33. Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51: 1173-1182, 1986
34. Schumacker RE, Lomax RG: A beginner's guide to structural equation modeling, 2nd ed, Mahwah, NJ, Lawrence Erlbaum Associates, Inc., 2004
35. Bruno C, Fulford AD, Potts JR, McClintock R, Jones R, Cacucci BM, Gupta CE, Peacock M, Considine RV: Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: Correlation with the reduction in leptin. J Clin Endocrinol Metab 95: 159-166, 2010
36. Olmos JM, Vazquez LA, Amado JA, Hernandez JL, Gonzalez MJ: Mineral metabolism in obese patients following vertical banded gastroplasty. Obes Surg 18: 197-203, 2008
37. Flier JS: Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 83: 1407-1413, 1998
38. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G: Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197-207, 2000 (Pubitemid 30064908)
39. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL: Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140: 1630-1638, 1999 (Pubitemid 29149231)
40. Filip R, Raszewski G: Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women. Clin Endocrinol (Oxf) 70: 214-220, 2009
41. Kim SM, Kim SH, Lee JR, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY: Association of leptin receptor polymorphisms Lys109Arg and Gln223Arg with serum leptin profile and bone mineral density in Korean women. Am J Obstet Gynecol 198: 421-428, 2008
42. Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M, Sasaki A, Kawachi S, Yoshino K, Yasuda K: Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86: 5273-5276, 2001 (Pubitemid 33070248)
43. Weiss LA, Barrett-Connor E, von MD, Clark P: Leptin predicts BMD and bone resorption in older women but not older men: The Rancho Bernardo study. J Bone Miner Res 21: 758-764, 2006
44. Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K: Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post-menopausal women. Clin Endocrinol (Oxf) 55: 341-347, 2001 (Pubitemid 32823044)
45. Gordeladze JO, Reseland JE: A unified model for the action of leptin on bone turnover. J Cell Biochem 88: 706-712, 2003
46. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 49: 581-591, 2007
47. Sadideen H, Covic A, Goldsmith D: Mineral and bone disorder after renal transplantation: A review. Int Urol Nephrol 40: 171-184, 2008
48. Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L: Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 60: 257-265, 2001 (Pubitemid 32587562)